{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T11:39:47Z","timestamp":1779104387582,"version":"3.51.4"},"reference-count":0,"publisher":"Managed Care and Healthcare Communications, LLC","issue":"Suppl 7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Manag Care"],"published-print":{"date-parts":[[2020,8,1]]},"DOI":"10.37765\/ajmc.2020.88479","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T13:47:06Z","timestamp":1598363226000},"page":"S155-S161","source":"Crossref","is-referenced-by-count":3,"title":["Long-chain fatty acid oxidation disorders: managed care and specialty pharmacy implications"],"prefix":"10.37765","volume":"26","member":"24492","published-online":{"date-parts":[[2020,8,14]]},"container-title":["The American Journal of Managed Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T13:47:07Z","timestamp":1598363227000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajmc.com\/view\/long-chain-fatty-acid-oxidation-disorders-managed-care-and-specialty-pharmacy-implications"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,1]]},"references-count":0,"journal-issue":{"issue":"Suppl 7","published-online":{"date-parts":[[2020,8,14]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.37765\/ajmc.2020.88479","archive":["Portico"],"relation":{},"ISSN":["1936-2692","1088-0224"],"issn-type":[{"value":"1936-2692","type":"electronic"},{"value":"1088-0224","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,1]]}}}